« Previous | Next » | All Messages |  MGEN Message Board Home | recommend post |  Ignore Poster

MGEN News Med Gen Announces Newest Product

BOCA RATON, Fla.--(BUSINESS WIRE)--Med Gen Inc. (“MGEN”) (OTCBB:MGEN), manufacturers of nationally branded OTC healthier life products, introduced to analysts and investors its newest product fabUlust™, adding to its growing family of unique “one of a kind” Healthier Life™ products.

“Entering the estimated $120 billion sex enhancement market was not easy,” said Paul Kravitz, Med Gen Chairman & CEO, “However we really believe we have something great in fabUlust™. While we cannot disclose the trade secrets behind the formula until a Patent is issued, tests and other affirmative data indicate that the product will produce rapid arousal effects in women.” Statistics prove that 1 out of every 3 divorces are the result of sexual incompatibility of the couples.

The fabUlust™ delivery system will utilize the MedGen hands clean Roll-ON™ developed for its Painenz® product. It’s easy, quick and fun to use. The company is presently developing 60 and 120 second commercials to air starting in late June and July. Additional products are being developed for both men and women that will quickly follow and add to the category.

Management's corporate strategy is clear cut. To enter large markets with unique specialty products and novel delivery systems, producing the fastest growth opportunity for the company at a reasonable cost.

About Med Gen Inc.

Med Gen Inc., in business since 1996, manufactures and markets specialty products using its proprietary delivery system Spray’s the Way (“STW”). It is best known for producing the world’s first patented liquid spray snoring relief formula, Snorenz®. Since its existence, Med Gen has continued to develop its STW technology, introducing Good Nights Sleep® and the UnDiet® system into its family of brands. While STW technology is mainly used, the company also produces other products that deal with common health issues using other delivery systems. The company markets its products to distributors, major chain and drug stores, direct sales via the company web site and direct to consumer television, radio and print advertising. The company also distributes its brands internationally under various private labels or existing names.

Med Gen Inc. is a fully reporting company whose stock trades on the OTCBB under the symbol “MGEN”. For information contact Investor Relations 561-750-1100 or www.medgen.com.

This Press Release contains or incorporates by reference “forward looking statements" including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words “believes”, “suggests”, “anticipates”, “plans”, “expects”, and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.